Progentos Therapeutics Secures $65 Million Series A to Advance MS Treatment
Key Highlights Progentos Therapeutics launched and closed $65 million Series A round. Funding supports MS program through human proof…
Browsing Tag
Longwood Fund
2 posts
Solu Therapeutics Appoints Dr. Philip J. Vickers as New CEO
Solu Therapeutics, a precision-medicine company, announces the appointment of Dr. Philip J. Vickers as its new President and…